Rivaroxaban: Lancet is under pressure to retract “unreliable” paper as investigation drags on Post date 23 July 2024 ← UN agency calls for funding boost and political will to end AIDS by 2030 → GLP-1 agonists: US sees 700% increase over four years in number of patients without diabetes starting treatment